Additionally, they suggest a potential benefit conferred by the use of the polyphenol curcumin against Alzheimer’s disease-associated tau pathology, possibly through upregulating levels of the anti-tau co-chaperone BAG2. This evidence concerns the gene BAG2 and early-onset autosomal dominant Alzheimer disease.